BridgeBio Pharma: Attruby Peak Sales Set To Rise
BridgeBio Pharma raised Attruby peak-sales guidance as kidney-benefit data, fewer hospital days and competitor setbacks strengthen its…
Atticus Analysis NASDAQ
BridgeBio Pharma, Inc.
BBIO
1 article
$15B Market cap · 2026-09-08
Atticus Analysis 